Advisor Group Holdings, Inc. Talis Biomedical Corp Transaction History

Advisor Group Holdings, Inc.

  • $52.6 Billion
  • Q2 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
SELL
$0.45 - $11.67 $196 - $5,088
-436 Reduced 21.8%
1,564 $0
Q1 2022

May 04, 2022
SELL
$1.3 - $4.19 $195 - $628
-150 Reduced 6.98%
2,000 $2,000
Q3 2021

Nov 05, 2021
BUY
$6.02 - $12.46 $6,020 - $12,460
1,000 Added 86.96%
2,150 $13,000
Q1 2021

May 13, 2021
BUY
$11.2 - $27.8 $12,880 - $31,970
1,150 New
1,150 $15,000

About Talis Biomedical Corp

TLIS Quotes by TradingView
  • Ticker TLIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 26,619,200
  • Market Cap $42.6M
  • Description
  • Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...
More about TLIS
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email